Results 131 to 140 of about 59,490 (296)

Hemolytic uremic syndrome and IgA nephropathy in a child: Coincidence or not?

The Turkish Journal of Pediatrics, 2018
A previously healthy 18-month old boy, presenting with diarrhea, anemia, thrombocytopenia and acute renal failure was admitted to our hospital. Hemolytic uremic syndrome (HUS) was diagnosed with his clinical and laboratory findings.
Serra Sürmeli-Döven, Ali Delibaş, İclal Gürses, Uğur Raşit Kayacan, Banu Coşkun-Yılmaz, Kaan Esen, Emine Korkmaz, Fatih Özaltın   +7 more
doaj   +1 more source

Humoral immune response to Shiga Toxin 2 (Stx2) among Brazilian urban children with hemolytic uremic syndrome and healthy controls [PDF]

, 2014
Background: Shiga toxin (Stx)-producing Escherichia coli (STEC) infection is associated with hemolytic uremic syndrome (HUS), the main cause of acute renal failure in early childhood.
Guirro, Mirian, Guth, Beatriz Ernestina Cabilio, Piazza, Roxane Maria Fontes, Souza, Renato Lopes de   +3 more
core   +2 more sources

Prepartum Eculizumab for prevention of atypical hemolytic uremic syndrome: A case report [PDF]

, 2016
Gianluigi Ardissino, Giulia Maria Baffero, Manuela Wally Ossola, Benedetta Agnoli, Francesca Tel, Michela Perrone, Stefania Salardi, Martina Sgarbanti, Martina Sgarbanti   +8 more
openalex   +1 more source

Clinical case of thrombotic microangiopathy in obstetric practice

Сеченовский вестник, 2017
Trombotic microangiopathy is heterogeneous group of the diseases united by a community of a histological and clinical implications at difference of pathogenetic mechanisms, presents clinical-morphological syndrome characterizing a lesion of vessels of a ...
M. N. Mochalova, T. E. Belokrinitskaya, T. V. Haven, E. M. Shifman, K. G. Shapovalov, S. V. Kostromitin   +5 more
doaj  

Microvascular changes in renal allografts associated with FK506 (Tacrolimus) therapy [PDF]

, 1996
FK506 (Tacrolimus) recently has been shown to be an effective immunosuppressant after renal transplantation. It is associated with less hypertension, hypercholesterolemia and steroid use compared with cyclosporine.
, , , A. C. Tsamandas, A. J. Demetris, Demetris, Erden, Fries, Holman, Kant, Kerns, Kumano, Lieberman, M. Jordan, M. Magnone, McCauley, McCauley, Nalesnik, Ochiai, P. S. Randhawa, Peters, R. Shapiro, Randhawa, Schmidt, Shapiro, Shulman, T. E. Starzl, The, Thiru, Todo, Todo, Van Buren, Wang, Yamada   +33 more
core   +1 more source

Síndrome Hemolítico Urémico Atípico en Cuidados Intensivos: Caso Clínico de un Adulto [PDF]

, 2016
info:eu-repo/semantics ...
Agudo, I, Azevedo, L, Bento, L, Cavaco, R, Germano, N, Souto-Moura, T   +5 more
core   +1 more source

Shigatoxin-associated hemolytic uremic syndrome: current molecular mechanisms and future therapies

Drug Design, Development and Therapy, 2012
Lindsay S Keir,1 Stephen D Marks,2 Jon Jin Kim21Academic Renal Unit, University of Bristol, Bristol; 2Department of Paediatric Nephrology, Great Ormond Street Hospital NHS Foundation Trust, London, United KingdomAbstract: Hemolytic uremic syndrome is the
Keir LS, Marks SD, Kim JJ
doaj  

MALIGNANT ARTERIAL HYPERTENSION IN A CHILD WITH ATYPICAL HEMOLYTIC-UREMIC SYNDROME

Мать и дитя в Кузбассе, 2022
Atypical hemolytic-uremic syndrome (aHUS) is a rare orphan disease. In the Altai Region, two cases of aHUS among children have been recorded. The disease is characterized by a severe course with high mortality, frequent development of complications and a
Олеся Алексеевна Зенченко, Евгений Васильевич Скударнов, Галина Ивановна Выходцева, Юлия Васильевна Волкова, Людмила Михайловна Новикова, Ольга Михайловна Малюга   +5 more
doaj  

Spontaneous hemolytic uremic syndrome triggered by complement factor H lacking surface recognition domains [PDF]

, 2007
Matthew C. Pickering, Elena Goicoechea de Jorge, Rubén Martínez-Barricarte, Sergio Recalde, Alfredo García‐Layana, Kirsten L. Rose, Jill Moss, Mark Walport, H. Terence Cook, Santiago Rodrı́guez de Córdoba, Marina Botto   +10 more
openalex   +1 more source

The Janus-faced nature of complement in hemodialysis: interplay between complement, inflammation, and bioincompatibility unveiling a self-amplifying loop contributing to organ damage

Frontiers in Nephrology
In hemodialysis (HD), complement activation, bioincompatibility, and inflammation are intricately intertwined. In the 1970s, as HD became a routine therapy, the observation of complement pathway activation and transient leukopenia by cellulosic dialysis ...
Bernard Canaud, Peter Stenvinkel, Rebecca Scheiwe, Sonja Steppan, Sudhir Bowry, Giuseppe Castellano   +5 more
doaj   +1 more source